| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
52,730,000 |
| Market
Cap: |
119.70(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.35 - $9.66 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Omega Therapeutics is delveoping an approach to use mRNA therapeutics as programmable epigenetic medicines by utilizing its OMEGA Epigenomic Programming platform. Co. designs and engineers its mRNA therapeutics, which are programmable and modular epigenetic medicines, called Omega Epigenomic Controllers (OECs) to target EpiZips for Precision Genomic Control. Co.'s pipeline consists of early-stage, preclinical programs that span oncology, multigenic diseases. Co. has conducted in vivo preclinical studies of its OECs in multiple disease models for various indications, including hepatocellular carcinoma, non-small cell lung cancer, and acute respiratory distress syndrome.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
3,323,310 |
| Total Buy Value |
$0 |
$0 |
$0 |
$19,208,732 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
10,000 |
55,000 |
| Total Sell Value |
$0 |
$0 |
$80,000 |
$440,000 |
| Total People Sold |
0 |
0 |
1 |
1 |
| Total Sell Transactions |
0 |
0 |
2 |
6 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Young Richard A |
Director |
– • – |
2023-06-02 |
4 |
AS |
$8.00 |
$40,000 |
D/D |
(5,000) |
739,118 |
|
-76% |
|
| Young Richard A |
Director |
– • – |
2023-05-01 |
4 |
AS |
$8.00 |
$40,000 |
D/D |
(5,000) |
744,118 |
|
-60% |
|
| Young Richard A |
Director |
– • – |
2023-04-06 |
4 |
AS |
$8.00 |
$40,000 |
D/D |
(5,000) |
749,118 |
|
-53% |
|
| Young Richard A |
Director |
– • – |
2023-03-17 |
4 |
AS |
$8.00 |
$80,000 |
D/D |
(10,000) |
754,118 |
|
-52% |
|
| Flagship Pioneering Fund Vii, L.p. |
10% Owner |
– – • |
2023-02-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,329,324 |
|
-21% |
|
| Afeyan Noubar |
Director |
– • • |
2023-02-27 |
4 |
B |
$5.78 |
$19,208,732 |
I/I |
3,323,310 |
1,329,324 |
2.25 |
-21% |
|
| Young Richard A |
Director |
– • – |
2023-01-10 |
4 |
AS |
$8.00 |
$160,000 |
D/D |
(20,000) |
764,118 |
|
7% |
|
| Young Richard A |
Director |
– • – |
2022-09-14 |
4 |
AS |
$8.00 |
$80,000 |
D/D |
(10,000) |
784,118 |
|
17% |
|
| Karande Mahesh |
President and CEO |
• • – |
2022-02-01 |
4 |
OE |
$0.53 |
$5,989 |
D/D |
11,300 |
117,711 |
|
- |
|
| Flagship Venturelabs V Llc |
10% Owner |
– – • |
2021-08-03 |
4 |
B |
$17.00 |
$19,999,973 |
I/I |
1,176,469 |
1,617,646 |
1.5 |
-9% |
|
| Flagship Venturelabs V Llc |
10% Owner |
– – • |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
I/I |
22,528,741 |
1,323,529 |
|
- |
|
| Afeyan Noubar |
Director |
– • • |
2021-08-03 |
4 |
B |
$17.00 |
$19,999,973 |
I/I |
1,176,469 |
1,617,646 |
2.25 |
-9% |
|
| Afeyan Noubar |
Director |
– • • |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
I/I |
22,528,741 |
1,323,529 |
|
- |
|
| Sawhney Roger |
Chief Financial Officer |
• – – |
2021-08-03 |
4 |
B |
$17.00 |
$49,997 |
D/D |
2,941 |
2,941 |
2.74 |
-9% |
|
| Invus Public Equities Advisors, Llc |
10% Owner |
– – • |
2021-08-03 |
4 |
B |
$17.00 |
$14,875,000 |
D/D |
875,000 |
2,273,530 |
2.45 |
-9% |
|
| Invus Public Equities Advisors, Llc |
10% Owner |
– – • |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,323,530 |
1,398,530 |
|
- |
|
| Berry David A |
Director |
– • – |
2021-08-03 |
4 |
B |
$17.00 |
$902,394 |
D/D |
53,082 |
53,082 |
2.39 |
-9% |
|
| Invus Public Equities Advisors, Llc |
10% Owner |
– – • |
2021-07-30 |
4 |
B |
$16.14 |
$1,210,343 |
D/D |
75,000 |
75,000 |
2.45 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.08 (3.4%) 
